[1] Courbon G, Rinaudo-Gaujous M, Blasco-Baque V, et al. Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat [J]. Ann Rheum Dis, 2019, 78(5):594-599. [2] 赵莹,林雪峰.中重度慢性牙周炎上颌中切牙区解剖形态的锥形束CT测量分析[J].中华口腔医学研究杂志(电子版),2018,12(6):369-374. [3] Komaki M. Pericytes in the periodontal ligament [J]. Adv Exp Med Biol, 2019, 1122: 169-186. [4] Zhang X, Yuan X, Xu Q, et al. Molecular basis for periodontal ligament adaptation to in vivo loading [J]. J Dent Res, 2019, 98(3):331-338. [5] 潘春玲,韩伶娜,宋佳,等.NLRP3在牙龈卟啉单胞菌感染牙周膜细胞中的表达[J].中国医科大学学报,2016,45(3): 201-204. [6] 杨萍,周玉平,夏晴,等.HO-1介导黄芪甲苷抗原代心肌细胞缺氧/复氧损伤作用研究[J].天津中医药,2019,36(1): 79-82. [7] 臧凯宏,吴建军,段海婧,等.黄芪甲苷Ⅳ对溃疡性结肠炎大鼠的作用及其机制研究[J].中国临床药理学杂志,2019,35(1): 48-51. [8] 王芳,曾煦欣,毛建文,等.黄芪散含药血清对大鼠骨髓间充质干细胞增殖和分化功能的影响[J].中成药,2017,39(7): 1478-1482. [9] Xu XY, Li X, Wang J, et al. Concise review: periodontal tissue regeneration using stem cells: strategies and translational considerations [J]. Stem Cells Transl Med, 2019, 8(4):392-403. [10] Coyac BR, Detzen L, Doucet P,et al. Periodontal reconstruction by heparan sulfate mimetic-based matrix therapy in Porphyromonas gingivalis-infected mice [J]. Heliyon, 2018, 4(8):e00719. [11] García-Hernández AL, Muñoz-Saavedra ÁE, González-Alva P, et al. Upregulation of proteins of the NLRP3 inflammasome in patients with periodontitis and uncontrolled type 2 diabetes [J]. Oral Dis, 2019, 25(2):596-608. [12] Isaza-Guzmán DM, Medina-Piedrahíta VM, Gutiérrez-Henao C, et al. Salivary levels of NLRP3 inflammasome-related proteins as potential biomarkers of periodontal clinical status [J]. J Periodontol, 2017, 88(12):1329-1338. [13] 余素姣,谭慧.黄芪甲苷通过炎症小体活化影响软骨细胞炎性因子的表达[J].中国组织工程研究,2019, 23(11):1652-1656. [14] Wan Y, Xu L, Wang Y, et al. Preventive effects of astragaloside Ⅳ and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome [J]. Eur J Pharmacol, 2018, 15(833): 545-554. [15] Leng B, Zhang Y, Liu X, et al. Astragaloside Ⅳ suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4/NF-κB and CaSR [J]. Mediators Inflamm, 2019, 2019: 1082497. |